Clinical Trial Update: Bioneer Q-RFIA Clinical Evaluation

View source ↗

Summary

Updates the status of a clinical evaluation of the Bioneer Q-RFIA for tuberculosis, including multidrug-resistant tuberculosis, noting the study is active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: Foundation for Innovative New Diagnostics, Switzerland | Conditions: Tuberculosis, Multidrug-Resistant | Status: ACTIVE_NOT_RECRUITING